BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11570641)

  • 1. Effect of anti-IL-6 and anti-10 monoclonal antibodies on the suppression of the normal T lymphocyte mitogenic response by steady state sickle cell disease sera.
    Taylor S; Shacks S; Qu Z
    Immunol Invest; 2001 Aug; 30(3):209-19. PubMed ID: 11570641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro suppression of the normal mitogenic T lymphocyte response by steady state sickle cell disease sera.
    Taylor S; Shacks S; Qu Z; Colaco V
    Immunol Invest; 1997; 26(5-7):561-8. PubMed ID: 9399099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined effects of in vitro penicillin and sickle cell disease sera on normal lymphocyte functions.
    Taylor SC; Shacks SJ; Qu Z; Bryant P
    J Natl Med Assoc; 2002 Aug; 94(8):678-85. PubMed ID: 12152923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of suppressor cells to T- and B-cell proliferative responses and immunoglobulin production by monoclonal antibodies recognizing the CD3 T-cell differentiation antigen.
    Kunicka JE; Platsoucas CD
    Cell Immunol; 1988 Oct; 116(1):195-215. PubMed ID: 2901914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation-induced T cell apoptosis by monocytes from stem cell products.
    Ino K; Ageitos AG; Singh RK; Talmadge JE
    Int Immunopharmacol; 2001 Jul; 1(7):1307-19. PubMed ID: 11460311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphocyte blastogenic responses in sickle cell disease.
    Taylor S; Shacks S; Villicana S; Olivares J; Dinkins G
    Immunol Invest; 1991 Dec; 20(7):645-55. PubMed ID: 1757121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphocyte activation and cytokine production in autoimmune hemolytic anaemia (AIHA).
    Fagiolo E; Abenante L
    Autoimmunity; 1996; 24(3):147-56. PubMed ID: 9020407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional properties of the 50 kd protein associated with the E-receptor on human T lymphocytes: suppression of IL 2 production by anti-p50 monoclonal antibodies.
    Tadmori W; Reed JC; Nowell PC; Kamoun M
    J Immunol; 1985 Mar; 134(3):1709-16. PubMed ID: 2981919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired T and NK cell response of bone marrow and peripheral blood stem cell products to interleukin (IL)-2.
    Ozerol I; Ageitos A; Heimann DG; Talmadge JE
    Int J Immunopharmacol; 1999 Aug; 21(8):509-21. PubMed ID: 10458540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL 2 alone is mitogenic only for Tac-positive lymphocytes in human peripheral blood.
    Taylor DS; Kern JA; Nowell PC
    J Immunol; 1986 Mar; 136(5):1620-4. PubMed ID: 3005396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo production of type 1 cytokines in healthy sickle cell disease patients.
    Taylor SC; Shacks SJ; Qu Z
    J Natl Med Assoc; 1999 Nov; 91(11):619-24. PubMed ID: 10641497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression by Trypanosoma brucei rhodesiense of the capacities of human T lymphocytes to express interleukin-2 receptors and proliferate after mitogenic stimulation.
    Kierszenbaum F; Muthukkumar S; Beltz LA; Sztein MB
    Infect Immun; 1991 Oct; 59(10):3518-22. PubMed ID: 1894358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pattern of serum cytokine expression and T-cell subsets in sickle cell disease patients in vaso-occlusive crisis.
    Musa BO; Onyemelukwe GC; Hambolu JO; Mamman AI; Isa AH
    Clin Vaccine Immunol; 2010 Apr; 17(4):602-8. PubMed ID: 20130127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell subsets in human lymphocytes maintained in IL-2 medium after PHA or mixed lymphocyte reaction activation.
    Kurnick JT; Warrens AR; Moscicki RA; Leary CP
    Clin Immunol Immunopathol; 1983 Jun; 27(3):444-51. PubMed ID: 6223760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Competition of IL-1 and IL-1ra determines lymphocyte response to delayed stimulation with PHA.
    Dabrowski MP; Stankiewicz W; Płusa T; Chciałowski A; Szmigielski S
    Mediators Inflamm; 2001 Jun; 10(3):101-7. PubMed ID: 11545246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The anti-T cell monoclonal antibody 9.3 (anti-CD28) provides a helper signal and bypasses the need for accessory cells in T cell activation with immobilized anti-CD3 and mitogens.
    Baroja ML; Lorre K; Van Vaeck F; Ceuppens JL
    Cell Immunol; 1989 Apr; 120(1):205-17. PubMed ID: 2539266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humoral-mediated suppression of interleukin 2-dependent target cell proliferation in acquired immune deficiency syndrome (AIDS): interference with normal IL-2 receptor expression.
    Donnelly RP; La Via MF; Tsang KY
    Clin Exp Immunol; 1987 Jun; 68(3):488-99. PubMed ID: 3115647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune functions of tumor necrosis factor. I. Tumor necrosis factor induces apoptosis of mouse thymocytes and can also stimulate or inhibit IL-6-induced proliferation depending on the concentration of mitogenic costimulation.
    Hernández-Caselles T; Stutman O
    J Immunol; 1993 Oct; 151(8):3999-4012. PubMed ID: 8409382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibody OKT11A inhibits and recombinant interleukin 2 (IL 2) augments expression of IL 2 receptors at a pretranslational level.
    Reed JC; Greene WC; Hoover RG; Nowell PC
    J Immunol; 1985 Oct; 135(4):2478-82. PubMed ID: 3928749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zinc deficiency and blood lymphocyte function with sickle cell disease.
    Daeschner CW; Carpentieri U; Goldman AS; Haggard ME
    Scand J Haematol; 1985 Aug; 35(2):186-90. PubMed ID: 3876597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.